Colin Kellaher

The Wall Street Journal

Roku Poaches Stitch Fix Finance Chief Dan Jedda

By: Colin Kellaher

Roku said Dan Jedda, who has been chief financial officer of personal shopping and styling service Stitch Fix since late 2020, will join the streaming company as finance chief on May 1.

The Wall Street Journal

General Motors to Offer Voluntary Buyouts

By: Colin Kellaher

Auto maker says it is looking to cut $2 billion in annual fixed costs.

The Wall Street Journal

Honeywell Taps COO Kapur as Next CEO

By: Colin Kellaher

Industrial company says the 34-year company veteran will succeed current CEO Darius Adamczyk in June.

The Wall Street Journal

Franchise Group Stock Rises After Takeover Proposal

By: Colin Kellaher

Shares of Franchise Group jumped more than 10% on Monday after the investment firm that owns retailers said it received a non-binding takeover proposal. The $30-a-share cash bid from the undisclosed suitor represents a 32% premium to Friday's closing price of $22.75. The company owns consumer-facin

The Wall Street Journal

Papa John’s Financial Chief Ann Gugino Resigns

By: Colin Kellaher

Move marks the latest in a series of leadership changes at the pizza chain.

The Wall Street Journal

Bath & Body Works Financial Chief Wendy Arlin to Leave

By: Colin Kellaher

Fragrance and body-care products retailer has begun a search for a replacement with the assistance of an executive-search firm.

The Wall Street Journal

W&T Offshore Chief Financial Officer Janet Yang Leaving

By: Colin Kellaher

Independent oil and natural gas producer said Trey Hartman, vice president and chief accounting officer, will serve in interim.

The Wall Street Journal

Groupon Brings in New Finance Chief From Top Shareholder Pale Fire

By: Colin Kellaher

The struggling local-deals site is in the process of reshaping its management.

The Wall Street Journal

Catalent Finance Chief Leaves Company Amid Profit Warning

By: Colin Kellaher

Move comes as the company warned that productivity issues and higher-than-expected costs would have a material impact on its results.

The Wall Street Journal

Baxter Selling Biopharma-Solutions Arm for $4.25 Billion

By: Colin Kellaher

The sale to private-equity firms Advent International and Warburg Pincus comes as the medical-products company streamlines its focus.